|
HY-122808-100mg
|
MedChemexpress LLC
|
(-)-Camphoric acid [CAS 560-09-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-122808-1mL
|
MedChemexpress LLC
|
(-)-Camphoric acid [CAS 560-09-8] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-W017423-25g
|
MedChemexpress LLC
|
(-)-Carvone [CAS 6485-40-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W017423-50g
|
MedChemexpress LLC
|
(-)-Carvone [CAS 6485-40-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N0898A-10mg
|
MedChemexpress LLC
|
(-)-Catechin [CAS 18829-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0898A-25mg
|
MedChemexpress LLC
|
(-)-Catechin [CAS 18829-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0898A-5mg
|
MedChemexpress LLC
|
(-)-Catechin [CAS 18829-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0898A-50mg
|
MedChemexpress LLC
|
(-)-Catechin [CAS 18829-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0898A-1mL
|
MedChemexpress LLC
|
(-)-Catechin [CAS 18829-70-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N0356-1mg
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2]
|
|
Cancer-programmed cell death
|
|
|
HY-N0356-10mg
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2]
|
|
Cancer-programmed cell death
|
|
|
HY-N0356-5mg
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2]
|
|
Cancer-programmed cell death
|
|
|
HY-N0356-1mL
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-135190-1mL
|
MedChemexpress LLC
|
(-)-Cedrene [CAS 469-61-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-135190-5mL
|
MedChemexpress LLC
|
(-)-Cedrene [CAS 469-61-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-110015-10mg
|
MedChemexpress LLC
|
(-)-Chromanol 293B [CAS 163163-24-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N7010-1mg
|
MedChemexpress LLC
|
(-)-Corynoxidine [CAS 57906-85-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7010-5mg
|
MedChemexpress LLC
|
(-)-Corynoxidine [CAS 57906-85-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3729-1mg
|
MedChemexpress LLC
|
(-)-Denudatin B [CAS 87402-88-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N3729-5mg
|
MedChemexpress LLC
|
(-)-Denudatin B [CAS 87402-88-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14645-10mg
|
MedChemexpress LLC
|
(-)-DHMEQ [CAS 287194-40-5]
|
|
Cancer-programmed cell death
|
|
|
HY-14645-2mg
|
MedChemexpress LLC
|
(-)-DHMEQ [CAS 287194-40-5]
|
|
Cancer-programmed cell death
|
|
|
HY-14645-25mg
|
MedChemexpress LLC
|
(-)-DHMEQ [CAS 287194-40-5]
|
|
Cancer-programmed cell death
|
|
|
HY-14645-5mg
|
MedChemexpress LLC
|
(-)-DHMEQ [CAS 287194-40-5]
|
|
Cancer-programmed cell death
|
|
|
HY-14645-1mL
|
MedChemexpress LLC
|
(-)-DHMEQ [CAS 287194-40-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
